Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark B Effron

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 19, 2015
"Real-World" Comparison of Prasugrel With Ticagrelor in Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention in the United StatesCynthia Larmore, Mark B Effron, Cliff Molife, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 9, 2017
The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: Insights from the TRANSLATE-ACS studyMark B Effron, Tracy Y Wang, Gregg C Fonarow, et al.
Circulation. Cardiovascular Quality and Outcomes|June 4, 2015
Early Medication Nonadherence After Acute Myocardial Infarction: Insights into Actionable Opportunities From the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) StudyRobin Mathews, Eric D Peterson, Emily Honeycutt, et al.
Journal of Medical Economics|June 19, 2015
Comparison of healthcare resource utilization and costs in patients hospitalized for acute coronary syndrome managed with percutaneous coronary intervention and receiving prasugrel or ticagrelorCliff Molife, Feride Frech-Tamas, Mitch DeKoven, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 14, 2005
Physical and chemical compatibility of drotrecogin alfa (activated) with 34 drugs during simulated Y-site administrationHenry J Mann, Sarah L Demmon, Debra A Boelk, et al.
Journal of the American College of Cardiology|October 23, 2024
Platelet FcγRIIa as a Marker of Cardiovascular Risk After Myocardial InfarctionDavid J Schneider, Sean R McMahon, Dominick J Angiolillo, et al.
Stroke|November 23, 2007
Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)Harold P Adams, Mark B Effron, James Torner, et al.
Journal of the American Heart Association|October 7, 2017
Multivessel Versus Culprit Vessel-Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE-ACS Observational StudyHomam Ibrahim, Praneet K Sharma, David J Cohen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 17, 2026
Platelet FcɣRIIa Expression Refines Clinical Risk Assessment After Myocardial InfarctionDavid J Schneider, Sean R McMahon, Dominick J Angiolillo, et al.
Circulation. Cardiovascular Interventions|September 26, 2013
Effect on platelet reactivity from a prasugrel loading dose after a clopidogrel loading dose compared with a prasugrel loading dose alone: Transferring From Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients (TRIPLET): a randomized controlled trialJean G Diodati, Jorge F Saucedo, John K French, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 19, 2015
"Real-World" Comparison of Prasugrel With Ticagrelor in Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention in the United StatesCynthia Larmore, Mark B Effron, Cliff Molife, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 9, 2017
The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: Insights from the TRANSLATE-ACS studyMark B Effron, Tracy Y Wang, Gregg C Fonarow, et al.
Circulation. Cardiovascular Quality and Outcomes|June 4, 2015
Early Medication Nonadherence After Acute Myocardial Infarction: Insights into Actionable Opportunities From the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) StudyRobin Mathews, Eric D Peterson, Emily Honeycutt, et al.
Journal of Medical Economics|June 19, 2015
Comparison of healthcare resource utilization and costs in patients hospitalized for acute coronary syndrome managed with percutaneous coronary intervention and receiving prasugrel or ticagrelorCliff Molife, Feride Frech-Tamas, Mitch DeKoven, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 14, 2005
Physical and chemical compatibility of drotrecogin alfa (activated) with 34 drugs during simulated Y-site administrationHenry J Mann, Sarah L Demmon, Debra A Boelk, et al.
Journal of the American College of Cardiology|October 23, 2024
Platelet FcγRIIa as a Marker of Cardiovascular Risk After Myocardial InfarctionDavid J Schneider, Sean R McMahon, Dominick J Angiolillo, et al.
Stroke|November 23, 2007
Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)Harold P Adams, Mark B Effron, James Torner, et al.
Journal of the American Heart Association|October 7, 2017
Multivessel Versus Culprit Vessel-Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE-ACS Observational StudyHomam Ibrahim, Praneet K Sharma, David J Cohen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 17, 2026
Platelet FcɣRIIa Expression Refines Clinical Risk Assessment After Myocardial InfarctionDavid J Schneider, Sean R McMahon, Dominick J Angiolillo, et al.
Circulation. Cardiovascular Interventions|September 26, 2013
Effect on platelet reactivity from a prasugrel loading dose after a clopidogrel loading dose compared with a prasugrel loading dose alone: Transferring From Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients (TRIPLET): a randomized controlled trialJean G Diodati, Jorge F Saucedo, John K French, et al.
Pageof 10